The Neuroimaging Market is estimated at US$42.1 billion in 2026 and is projected to grow at a CAGR of 6.7% to reach US$70.7 billion by 2034.
Relevant uses and settings include stroke care, neurodegenerative disease assessment, oncology, psychiatric research, surgical planning, and cognitive science. At the same time, the market faces high equipment costs, interpretation complexity, reimbursement constraints, and uneven access to advanced imaging capacity.
This product will be delivered within 1-3 business days.
Market Overview
The Neuroimaging Market covers imaging technologies and associated software used to visualize brain structure, function, blood flow, and neurological change across clinical and research settings.Relevant uses and settings include stroke care, neurodegenerative disease assessment, oncology, psychiatric research, surgical planning, and cognitive science. At the same time, the market faces high equipment costs, interpretation complexity, reimbursement constraints, and uneven access to advanced imaging capacity.
Key Companies Analysed
- GE HealthCare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Hitachi, Ltd.
- Shimadzu Corporation
- Samsung Medison
- Bruker Corporation
- PerkinElmer, Inc.
- Agfa-Gevaert Group
- Carestream Health
- Hologic, Inc.
- Natus Medical Incorporated
- Nihon Kohden Corporation
- United Imaging Healthcare
- NeuroLogica Corp.
- Hyperfine, Inc.
- Esaote S.p.A.
- Olympus Corporation
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Neuroimaging Market Overview
3. Neuroimaging Market Dynamics
4. Neuroimaging Market Strategic Analysis
5. Global Neuroimaging Market Size, Share and Forecast, 2025-2034
6. North America Neuroimaging Market Outlook to 2034
7. Europe Neuroimaging Market Outlook to 2034
8. Asia-Pacific Neuroimaging Market Outlook to 2034
9. Middle East and Africa Neuroimaging Market Outlook to 2034
10. South and Central America Neuroimaging Market Outlook to 2034
11. Neuroimaging Market Competitive Landscape
12. Appendix
Companies Mentioned
- GE HealthCare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Hitachi, Ltd.
- Shimadzu Corporation
- Samsung Medison
- Bruker Corporation
- PerkinElmer, Inc.
- Agfa-Gevaert Group
- Carestream Health
- Hologic, Inc.
- Natus Medical Incorporated
- Nihon Kohden Corporation
- United Imaging Healthcare
- NeuroLogica Corp.
- Hyperfine, Inc.
- Esaote S.p.A.
- Olympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 42.1 Billion |
| Forecasted Market Value ( USD | $ 70.7 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
